Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Recs

0
Player Avatar Jonock (< 20) Submitted: 8/29/2011 3:02:33 PM : Outperform Start Price: $56.88 ALXN Score: +52.25

Generic dtugs

Featured Broker Partners


Advertisement